TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

APTASIGN

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

APTASIGN

ST13

US500000079252467

Classe

5, 10, 44

Pedido

79252467

Registro

6160568

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

34

Atualização mais recente

30/09/2025

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5, 10, 44

Data de depósito

11/12/2018

Data de registro

29/09/2020

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

29/09/2020

Última transação

30/09/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

5

Tipo de titular

03

Localização do titular

Seoul, KR

Examinador

BELZER,LYDIA M

Unidade examinadora

N60

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

BIOIS Co., Ltd

Representantes

Kisuk Lee Harness, Dickey & Pierce, PLC

Classificação técnica

Classes Nice

Classe 5Classe 10Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Medical diagnostic reagents for immunization from disease; diagnostic test reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; preparations for detecting genetic predispositions for medical purposes; diagnostic preparations for medical purposes for detecting genetic predispositions; reagents for use in medical genetic testing; in vitro diagnostic preparations for medical purposes; clinical diagnostic reagents for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis for medical or veterinary purposes; reagents for use in veterinary genetic testing; antibodies for medical purposes; aptamers for medical purposes; diagnostic antibodies for medical purposes; diagnostic aptamers for medical purposes

Classe 10

Medical apparatus and instruments, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical apparatus and instruments other than for dental purposes, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; apparatus for use in medical analysis, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical genetic testing devices, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical instruments in the nature of genetic fragment analyzers; medical instruments in the nature of genetic material analyzers; medical absorption analysis apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; DNA extraction and purification apparatus for medical purposes; medical apparatus and instruments in the fields of clinical diagnostics, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; body composition analyzers for medical purposes; body fluid analysis apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; in vitro diagnostic devices, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical apparatus and instruments for DNA analysis, other than for dental purposes; medical apparatus and instruments for RNA analysis, other than for dental purposes; medical apparatus and instruments for protein analysis, other than for dental purposes; gene and genetic testing apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; cancer diagnosis apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; diagnostic apparatus for medical purposes, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical body composition monitor; medical apparatus and instruments in the fields of clinical diagnostics, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; immunoassay apparatus for diagnostics, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; miniaturized sensors for medical use in gene analysis and diagnosis; veterinary apparatus and instruments for DNA analysis; veterinary apparatus and instruments for RNA analysis; veterinary apparatus and instruments for protein analysis

Classe 44

Medical and healthcare services relating to DNA and genetics analysis and diagnosis and genetic testing; medical analysis services relating to the treatment of persons; physical examination services; medical services relating to the removal, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow; medical analysis for the diagnosis and treatment of persons; RNA or DNA analysis for cancer diagnosis and prognosis; medical analysis services for cancer diagnosis and prognosis; genetic testing for medical purposes; provision of genetic testing for medical treatment purposes; provision of genetic information for medical treatment purposes; medical examination services; rental of medical machines and apparatus; rental of medical apparatus; performing medical diagnostic services involving medical testing and analysis for diagnostic and treatment purposes; medical testing services relating to the diagnosis and treatment of disease; Medical analysis services for the analysis of blood samples for diagnostic and treatment purposes provided by a medical laboratory; Medical analysis services for the analysis of samples taken from patients for diagnostic and treatment purposes provided by a medical laboratory; Medical analysis services for the analysis of blood samples taken from patients for diagnostic and treatment purposes provided by a medical laboratory

Publicações

Histórico de despachos e eventos da marca no USPTO.

34 publicações encontradas

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

29/09/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

06/02/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

15/01/2021

FIMP

FINAL DISPOSITION PROCESSED

15/01/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

29/12/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

29/09/2020

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

07/08/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

22/07/2020

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

22/07/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

14/07/2020

PUBO

PUBLISHED FOR OPPOSITION

14/07/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

24/06/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/06/2020

LOPR

LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN

28/10/2019

LOPT

LETTER OF PROTEST EVIDENCE FORWARDED

17/10/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

25/09/2019

ALIE

ASSIGNED TO LIE

24/09/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

24/09/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

24/09/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

24/09/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

14/08/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

13/08/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

13/08/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

26/07/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

26/07/2019

RFNP

REFUSAL PROCESSED BY IB

12/04/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

28/03/2019

RFRR

REFUSAL PROCESSED BY MPU

28/03/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

20/03/2019

CNRT

NON-FINAL ACTION WRITTEN

19/03/2019

DOCK

ASSIGNED TO EXAMINER

08/03/2019

MAFR

APPLICATION FILING RECEIPT MAILED

02/03/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

26/02/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

21/02/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace APTASIGN ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.